MEDICAL SOLUTIONS MANAGEMENT INC. 4
Accession 0001144204-09-000084
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 2:10 PM ET
Size
24.7 KB
Accession
0001144204-09-000084
Insider Transaction Report
- Purchase
Common Stock, $0.0001, par value per share
2008-12-31$0.20/sh+145,900$29,180→ 42,296,477 total(indirect: By Vicis Capital Master Fund)
- 544,935(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-12-30→ Common Stock (544,935 underlying) - 146,667(indirect: By Vicis Capital Master Fund)
Series A Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying) - 3,060,000(indirect: By Vicis Capital Master Fund)
Series CS Warrant to Purchase Common Stock No. CS-13
Exercise: $0.50Exp: 2012-12-07→ Common Stock (3,060,000 underlying) - 2,500,000(indirect: By Vicis Capital Master Fund)
Series CS Warrant to Purchase Common Stock No. CS-14
Exercise: $0.40Exp: 2012-12-16→ Common Stock (2,500,000 underlying) - 20,000,000(indirect: By Vicis Capital Master Fund)
Senior Secured Convertible Debenture
Exercise: $0.10Exp: 2008-06-28→ Common Stock (20,000,000 underlying) - 798,906(indirect: By Vicis Capital Master Fund)
Series D Convertible Preferred Stock, par value $0.0001
Exercise: $0.10→ Common Stock (79,890,600 underlying) - 10,500,000(indirect: By Vicis Capital Master Fund)
Senior Secured Convertible Debenture
Exercise: $0.10Exp: 2009-04-17→ Common Stock (10,500,000 underlying) - 153,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2012-03-16→ Common Stock (153,000 underlying) - 1,560,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2012-04-17→ Common Stock (1,560,000 underlying) - 146,667(indirect: By Vicis Capital Master Fund)
Series B Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying) - 120,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2010-12-30→ Common Stock (120,000 underlying)
- Purchase
Common Stock, $0.0001, par value per share
2008-12-31$0.20/sh+145,900$29,180→ 42,296,477 total(indirect: By Vicis Capital Master Fund)
- 146,667(indirect: By Vicis Capital Master Fund)
Series B Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying) - 3,060,000(indirect: By Vicis Capital Master Fund)
Series CS Warrant to Purchase Common Stock No. CS-13
Exercise: $0.50Exp: 2012-12-07→ Common Stock (3,060,000 underlying) - 10,500,000(indirect: By Vicis Capital Master Fund)
Senior Secured Convertible Debenture
Exercise: $0.10Exp: 2009-04-17→ Common Stock (10,500,000 underlying) - 20,000,000(indirect: By Vicis Capital Master Fund)
Senior Secured Convertible Debenture
Exercise: $0.10Exp: 2008-06-28→ Common Stock (20,000,000 underlying) - 146,667(indirect: By Vicis Capital Master Fund)
Series A Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying) - 153,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2012-03-16→ Common Stock (153,000 underlying) - 1,560,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2012-04-17→ Common Stock (1,560,000 underlying) - 798,906(indirect: By Vicis Capital Master Fund)
Series D Convertible Preferred Stock, par value $0.0001
Exercise: $0.10→ Common Stock (79,890,600 underlying) - 120,000(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2010-12-30→ Common Stock (120,000 underlying) - 544,935(indirect: By Vicis Capital Master Fund)
Warrant to Purchase Common Stock
Exercise: $0.20Exp: 2011-12-30→ Common Stock (544,935 underlying) - 2,500,000(indirect: By Vicis Capital Master Fund)
Series CS Warrant to Purchase Common Stock No. CS-14
Exercise: $0.40Exp: 2012-12-16→ Common Stock (2,500,000 underlying)
Footnotes (3)
- [F1]Immediately.
- [F2]Represents the indirect holdings of Vicis Capital LLC. All of the foregoing represents securities held directly by Vicis Capital Master Fund. Vicis Capital LLC acts as investment advisor to Vicis Capital Master Fund and therefore has voting and dispositive power over all the foregoing shares. For the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Vicis Capital LLC may be deemed to be the beneficial owner of, but hereby disclaims such beneficial ownership of, the foregoing shares.
- [F3]None.
Documents
Issuer
MEDICAL SOLUTIONS MANAGEMENT INC.
CIK 0000104401
Related Parties
1- filerCIK 0000104401
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 2:10 PM ET
- Size
- 24.7 KB